Advertisement
Canada markets close in 3 hours 46 minutes

  • S&P/TSX

    21,819.88
    -53.84 (-0.25%)
     

  • S&P 500

    5,017.91
    -53.72 (-1.06%)
     

  • DOW

    37,904.30
    -556.62 (-1.45%)
     

  • CAD/USD

    0.7305
    +0.0007 (+0.09%)
     

  • CRUDE OIL

    82.51
    -0.30 (-0.36%)
     

  • Bitcoin CAD

    87,744.95
    -938.45 (-1.06%)
     

  • CMC Crypto 200

    1,385.99
    +3.42 (+0.25%)
     

  • GOLD FUTURES

    2,341.90
    +3.50 (+0.15%)
     

  • RUSSELL 2000

    1,968.40
    -27.02 (-1.35%)
     

  • 10-Yr Bond

    4.7020
    +0.0500 (+1.07%)
     

  • NASDAQ

    15,482.51
    -230.24 (-1.47%)
     

  • VOLATILITY

    16.59
    +0.62 (+3.88%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Emerald Health is a Leader in the Canadian Cannabis Market with Huge Growing Capacity Planned

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / November 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Emerald Health Therapeutics, Inc. (EMHTF), a licensed Canadian producer of cannabis.

Its 50%-owned Pure Sunfarms joint venture in BC is completing a sophisticated 1.1 million square feet greenhouse; its Agro-Biotech operation in Québec is completing a 75,000 square feet indoor facility.

Read about the company’s potential growth drivers in this full comprehensive report READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/emerald-health/

ADVERTISEMENT

From an industry perspective, the recent legalization of cannabis sales for adult recreational use in Canada was a watershed moment for the entire industry and the Company. On October 17, 2018, Canada became the first G7 country and the second country in the world to legalize cannabis sales for adult recreational use.

The company has secured approximately 500 acres of hemp harvest in 2018 and has contracted for about 1000 acres in 2019 to 2022 with the goal of extracting low-cost cannabidiol (CBD).

What you might know about EMHTF operations network and recent business READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/emerald-health/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source